A subscription to JoVE is required to view this content. Sign in or start your free trial.
* These authors contributed equally
Here, we describe the structure and operating procedures, including microbial containment measures of a facility for "Wilding mice" using blood sampling for immunophenotyping as an example.
The use of laboratory mice with a natural microbiome, such as "Wildling mice", offers a promising research tool for both basic and applied science due to their close resemblance to the human superorganism. However, the breeding and maintenance of these mice, which harbor a diverse microbiome including bacteria, viruses, and parasites, pose significant challenges for animal husbandry facilities at research institutions. To address these challenges, a specialized facility concept was developed for housing "Wildling mice" at Charité - Universitätsmedizin Berlin. This approach involved designing a facility with specific structural features and operational protocols to effectively contain the natural microbiome, thereby protecting areas with higher hygiene standards.
A methodology for blood sampling from both specified pathogen-free (SPF) and "Wildling mice" for immunophenotyping is demonstrated, highlighting the workflow and biocontainment measures implemented in the facility. Remarkable results reveal that "Wildling mice" exposed to a natural microbiome develop distinct immune cell populations, which are significantly reduced in mice bred and maintained under stringent hygiene conditions.
The significance of this study lies in its potential to provide researchers with access to mice that possess a natural microbiome and a mature immune system similar to that of human adults. This approach could enhance the translatability of preclinical findings into clinical practice, thereby advancing the field of biomedical research.
Experimentation in mice is still indispensable in basic and applied science, such as preclinical and toxicological research. However, the standardization of hygiene in laboratory environments, aimed at reducing biological noise and minimizing variability in experimental results, has led to the exclusion of natural microbiota to a large extent. Thus, the conditions under which hygienically standardized, specified pathogen-free (SPF) laboratory mice are born and kept differ from the real-world conditions to which humans and animals are normally exposed. This mismatch between laboratory conditions and the natural environments in which human diseases occur gives rise to t....
The facility for "Wilding mice" and procedures involving living animals were approved by the responsible state office for animal experimentation, "Landesamt für Gesundheit und Soziales Berlin" (LAGeSo). The most important steps of the protocol are summarized in Figure 2.
1. Getting access to the Wilding facility
"Wilding mice" potentially harbor microorganisms typically excluded from SPF facilities, which poses a challenge to animal husbandry practices within research institutions that uphold stringent hygiene standards. Over the past 4 years, scientists and veterinarians at Charité - Universitätsmedizin Berlin and the German Centre for Protection of Laboratory Animals (Bf3R) have developed a facility dedicated to mice with a natural microbiome, incorporating stringent biocontainment measures through a collabor.......
Mice with a natural microbiome are a promising research tool for basic and applied science because of their closer resemblance to the human superorganism3,9,10,11,12. Attempts to incorporate biological complexity into mouse models have led to the development of various approaches, each with its own advantages and limitations3,
This work was supported by Charité 3R| Replace - Reduce - Refine. S.P.R. was supported by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) Emmy Noether-Programm RO 6247/1-1 (project ID 446316360), the DFG SFB1160 IMPATH (project ID 256073931), and the TRR 359 PILOT (project ID 491676693). S.J. was supported by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) JO 1216/2-1 and the German Multiple Sclerosis Society (DMSG e.V.).
....Name | Company | Catalog Number | Comments |
Alexa Fluor 700 anti-mouse CD45 antibody | BioLegend | 103127 | Clone 30F-11 |
Animal Chow | Altromin | 1324 | |
APC anti-mouse CD4 antibody | BioLegend | 100515 | Clone RM4-5 |
Blood collection tube | Greiner | 450475 | MiniCollect K3E, K3EDTA |
Bovine Serum Albumin | Sigma-Aldrich | A9647-100G | |
Brilliant Violet 605 anti-mouse TCR-beta chain antibody | BioLegend | 109241 | Clone H57-597 |
Brilliant Violet 785 anti-mouse CD8 antibody | BioLegend | 100749 | Clone 53-6.7 |
Capillary | Hirschmann | 9000210 | Hirschmann minicaps, Na-hep |
EDTA | Corning | 46-034-CI | |
FITC anti-mouse CD44 antibody | BioLegend | 103021 | Clone IM7 |
PerCP/Cyanine5.5 anti-mouse CD62L antibody | BioLegend | 104431 | Clone MEL-14 |
Phosphate-buffered Saline (10x) | Gibco | 12579099 | |
Phosphate-buffered Saline (1x) | Gibco | 14190094 | |
RBC lysing buffer | BioLegend | 420302 | |
Round Bottom Polystyrene Tube | Sarstedt | 55.476.005 | |
SYTOX Blue Dead Cell Stain | Invitrogen | S34852 | |
Tyvek overall (DuPont) | Fisher Scientific | 11371633 |
Explore More Articles
This article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved